Lataa...
Radioisotopes in management of metastatic prostate cancer
INTRODUCTION: Metastatic prostate cancer continues to be a leading cause of morbidity and mortality in men with prostate cancer. Over the last decade, the treatment landscape for patients with castrate-resistant disease has drastically changed, with several novel agents demonstrating an improvement...
Tallennettuna:
| Julkaisussa: | Indian J Urol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5054657/ https://ncbi.nlm.nih.gov/pubmed/27843209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-1591.189708 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|